Merrimack Pharmaceuticals... (MACK)
NASDAQ: MACK
· Real-Time Price · USD
15.14
0.01 (0.07%)
At close: May 17, 2024, 9:59 PM
Merrimack Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.35M | -1.18M | -1.43M | -1.6M | -1.68M | -1.54M | -1.53M | -1.61M | -1.89M | -2.46M | -3.09M | -3.57M | -3.97M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 191K | 160K | 129K | 98K | 68K | 71K | 97K | 133K | 209K | 397K | 728K | 1.07M | 1.45M |
Other Working Capital | 22K | 47K | 107K | 183K | 74K | 149K | 205K | 44K | 399K | 385K | 1.09M | 1.09M | 1.09M |
Other Non-Cash Items | -1.53M | -437K | -287K | -131K | 35K | -271K | -288K | -399K | -539K | -144K | -144K | -50K | -50K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 125K | -64K | 196K | 190K | 10K | 176K | -37K | -77K | 2.09M | 1.98M | 865K | 1.49M | -1.48M |
Operating Cash Flow | -2.48M | -1.52M | -1.41M | -1.47M | -1.74M | -1.74M | -1.91M | -2.09M | -135K | -218K | -1.64M | -1.06M | -4.06M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | 225M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -21.59M | -21.59M | -15.66M | -8.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 9M | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 227.99M | 3.13M | 3.13M | 130.19K | 139K | 445K | 445K | 539K | 539K | 144K | 144K | 50K | -261K |
Investing Cash Flow | 215.41M | -12.45M | -12.52M | -8.67M | 139K | 445K | 445K | 539K | 539K | 144K | 144K | 50K | -261K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.83M | 521K | 6.92M | 6.92M | 6.71M | 6.53M | n/a | n/a | n/a | 239K | 239K | 183K | 183K |
Financial Cash Flow | 1.83M | 521K | 6.92M | 6.92M | 6.71M | 6.53M | n/a | n/a | n/a | 239K | 239K | 183K | 183K |
Net Cash Flow | 214.76M | -13.45M | -7.01M | -3.22M | 5.11M | 5.24M | -1.47M | -1.55M | 404K | 165K | -1.26M | -826K | -4.13M |
Free Cash Flow | -2.48M | -1.52M | -1.41M | -1.47M | -1.74M | -1.74M | -1.91M | -2.09M | -135K | -218K | -1.64M | -1.06M | -4.06M |